These recalls involve products that pose serious risks of injury or death. Check if you own any of these products and take immediate action if needed.
783 critical product recalls that require immediate attention. These products have been identified as posing serious safety hazards.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects a specific lot due to contamination with N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 100-count bottles of 50 mg tablets due to excessive levels of N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and contact health providers for guidance.
Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects products with NDC 16714-050-01 due to high levels of a chemical impurity. Consumers should stop using the tablets immediately and contact healthcare providers.
Philips Medical Systems Nederland B.V. recalled 46 imaging systems on September 3, 2025. Deterioration of internal components may lead to loss of motorized movements. Healthcare providers must stop using the systems immediately and follow recall instructions.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 25 mg tablets due to high levels of N-Nitroso Desmethyl Chlorpromazine. Consumers must stop using the product immediately.
Philips Medical Systems Nederland B.V. recalled 174 OR tables on September 3, 2025. The recall affects models 722023, 722035, and 722015 due to potential failure of motorized movements. Users must stop using these devices immediately to prevent operational issues.
Sun Pharmaceutical Industries recalled 1,870 kits of Technetium Tc 99m Mertiatide on September 3, 2025. The recall follows failed dissolution specifications for a key ingredient. The affected kits were distributed nationwide and pose a high risk to patients.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride tablets on September 3, 2025. The recall affects tablets manufactured in India with high levels of a hazardous chemical. Consumers must stop using the product immediately and contact their healthcare provider.
Philips Medical Systems recalled 2,114 Allura Xper FD20 imaging systems on September 3, 2025. The systems may fail due to internal component deterioration, risking loss of motorized functionality. This recall affects 791 units in the U.S. and 1,323 globally.
Philips Medical Systems Nederland B.V. recalled five Biplane OR Tables on September 3, 2025, due to potential failure of internal components. The recall affects models 722020 and 722025, distributed worldwide. Users must stop using the affected devices immediately to avoid operational issues.
Philips Medical Systems Netherlands B.V. recalled 1,117 X-ray imaging systems on September 3, 2025. The recall affects product codes 722010, 722026, and 722003 due to potential internal component deterioration. This issue may render motorized movements inoperable, posing a risk to patient care.
Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 10 mg tablets sold nationwide due to contamination with N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and consult healthcare providers.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD10C model on September 3, 2025, due to a potential BIOS battery issue. The battery may deplete faster than expected, halting system startup without warning. Only two units are affected in the U.S.
Philips Medical Systems Nederland B.V. recalled 115 Allura Xper FD20/20 medical imaging devices on September 3, 2025. The BIOS battery may deplete faster than expected, halting the system during startup. The recall affects 34 devices in the U.S. and 81 internationally.
Philips Medical Systems recalled 298 Allura Xper FD20 operating room tables on September 3, 2025, due to a faulty BIOS battery. The battery depletes faster than expected, halting system start-up without warning. This recall affects 72 units in the U.S. and 226 units distributed internationally.
Philips Medical Systems recalled 585 Allura Xper FD10/10 imaging systems on September 3, 2025. The BIOS battery may deplete faster than expected, halting system start-up. This affects models 722005, 722011, and 722027 distributed worldwide.
New Spirit Naturals recalled 178 units of Super Muscle Support Powder on September 3, 2025. The product contains an undeclared allergen, milk, posing a serious health risk. Consumers should stop using the product immediately and contact the company for a refund.
Inpeco S.A. recalled one unit of the FlexLab X (FXX) System on September 3, 2025. The recall affects the Sample Integrity Module, which has not been FDA evaluated for safety. This may cause erroneous results or delays in patient testing.
New Spirit Naturals recalled 37 units of Ultra Whey Protein Powder on September 3, 2025. The recall is due to undeclared milk allergen ingredients. Consumers should stop using the product immediately.
Philips Medical Systems Nederland B.V. recalled 87 Allura Xper FD20/10 medical imaging devices on September 3, 2025. The BIOS battery may deplete faster than expected, halting the system's start-up process without warning. Healthcare providers and patients should stop using these devices immediately.